Fate Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly) Trends

Fate Therapeutics, Inc. (FATE)

1.46 -0.02 (-1.35%) USD | NASDAQ | Feb 26, 12:10

View EPS Basic from Tax Loss Carryforward (Quarterly) for FATE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

MannKind Corp.	--
Vertex Pharmaceuticals, Inc.	--
Ardelyx, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--